Clinical Trial Update: Pegfilgrastim as Support to Pediatric Sarcoma Patients Receiving Chemotherapy [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating pegfilgrastim as supportive care for pediatric sarcoma patients undergoing chemotherapy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sarcoma

Drugs mentioned

• Pegfilgrastim (pegfilgrastim)

Snippet

Sponsor: Amgen | Conditions: Sarcoma, Neutropenia | Phase 2 | Status: COMPLETED